ES2178651T3 - Compuestos carotenoides terapeuticos deispersables en agua. - Google Patents
Compuestos carotenoides terapeuticos deispersables en agua.Info
- Publication number
- ES2178651T3 ES2178651T3 ES94911015T ES94911015T ES2178651T3 ES 2178651 T3 ES2178651 T3 ES 2178651T3 ES 94911015 T ES94911015 T ES 94911015T ES 94911015 T ES94911015 T ES 94911015T ES 2178651 T3 ES2178651 T3 ES 2178651T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- deispersable
- therapeutic
- water
- carotenoid compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE PRESENTA UN AGENTE TERAPEUTICO PARA SU ADMINISTRACION MEDIANTE INYECCION O DE FORMA INTRAVENOSA QUE INCLUYE LA MECLA DE: A) UN COMPONENTE DISPERSIBLE O SOLUBLE EN AGUA; B) UN COMPONENTE EMULSIFICANTE; Y C) UN AGENTE TERAPEUTICO INSOLUBLE EN AGUA EN UN MEDIO PORTADOR ADECUADO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL793593 | 1993-03-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2178651T3 true ES2178651T3 (es) | 2003-01-01 |
Family
ID=3776794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94911015T Expired - Lifetime ES2178651T3 (es) | 1993-03-22 | 1994-03-22 | Compuestos carotenoides terapeuticos deispersables en agua. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5773026A (es) |
EP (1) | EP0689427B1 (es) |
JP (1) | JPH08510995A (es) |
AT (1) | ATE218855T1 (es) |
AU (1) | AU696956B2 (es) |
DE (1) | DE69430799T2 (es) |
ES (1) | ES2178651T3 (es) |
WO (1) | WO1994021232A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06501695A (ja) * | 1990-10-01 | 1994-02-24 | ブリガム・アンド・ウイメンズ・ホスピタル | 主要血管事象を抑制するためのベータ−カロテン及びビタミンe療法 |
US6132790A (en) * | 1991-09-06 | 2000-10-17 | Betatene Limited | Carotenoid composition |
AUPM493194A0 (en) * | 1994-04-08 | 1994-05-05 | Buckmeier, Julie A. | Therapeutic agent for inhibiting the conversion of epithelial cells to tumours |
AU700249B2 (en) * | 1994-04-08 | 1998-12-24 | Cognis Australia Pty Ltd | Carotenoid agent for inhibiting the conversion of epithelial cells to tumours |
EP0760650B1 (en) * | 1994-05-20 | 2002-07-31 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
DE19609476A1 (de) * | 1996-03-11 | 1997-09-18 | Basf Ag | Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen |
JP2001507702A (ja) * | 1996-12-31 | 2001-06-12 | インヘイル・セラピューティックス・システムズ・インコーポレテッド | 親水性賦形剤を有する疎水性薬剤の水性懸濁液を噴霧乾燥させる方法およびその方法によって作製された組成物 |
WO1998045241A2 (en) | 1997-04-04 | 1998-10-15 | Henkel Corporation | Lutein esters having high bioavailability |
US6767342B1 (en) | 2001-04-23 | 2004-07-27 | Evelyna D. Cantwell | Oxygen bandage system |
US7763649B2 (en) * | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
US7345091B2 (en) * | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050009788A1 (en) * | 2002-07-29 | 2005-01-13 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling connexin 43 expression |
CN1708480B (zh) * | 2002-07-29 | 2010-12-15 | 卡达克斯药物公司 | 用于抑制和改善疾病的类胡萝卜素结构类似物 |
US7723327B2 (en) * | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
US7320997B2 (en) * | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
US7375133B2 (en) * | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US8088363B2 (en) | 2002-10-28 | 2012-01-03 | Zeavision Llc | Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
WO2005102356A1 (en) * | 2004-04-14 | 2005-11-03 | Hawaii Biotech, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US20060058269A1 (en) * | 2004-04-14 | 2006-03-16 | Lockwood Samuel F | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US7351424B2 (en) * | 2004-07-22 | 2008-04-01 | Bio Lut S.A. De C.V. | Enhanced purity trans-lutein-ester compositions and methods of making same |
US20070065487A1 (en) * | 2005-09-21 | 2007-03-22 | Bio Lut S.A. De C.V. | Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof |
GB0523431D0 (en) * | 2005-11-17 | 2005-12-28 | Inst For Akvakulturforskning A | Method |
ES2764485T3 (es) * | 2009-05-07 | 2020-06-03 | Huntsman Corporation Australia Pty Ltd | Dispersantes en disoluciones con alto contenido electrolítico |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4572915A (en) * | 1984-05-01 | 1986-02-25 | Bioglan Laboratories | Clear micellized solutions of fat soluble essential nutrients |
AU595824B2 (en) * | 1985-08-30 | 1990-04-12 | Betatene Limited | Narurally-derived carotene/oil composition and the process for the production thereof by direct extraction of carotene from algae |
US4680314A (en) * | 1985-08-30 | 1987-07-14 | Microbio Resources, Inc. | Process for producing a naturally-derived carotene/oil composition by direct extraction from algae |
WO1989006977A1 (en) * | 1988-02-04 | 1989-08-10 | Board Of Regents, The University Of Texas System | Formulation and use of retinoids in treatment of cancer and other diseases |
JPH0225418A (ja) * | 1988-07-14 | 1990-01-26 | Kyorin Pharmaceut Co Ltd | イブジラスト脂肪乳剤およびその製造方法 |
DE3903056A1 (de) * | 1989-02-02 | 1990-08-09 | Braun Melsungen Ag | Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung |
GB8919172D0 (en) * | 1989-08-23 | 1989-10-04 | Univ Nottingham | Useful composition |
JPH06501695A (ja) * | 1990-10-01 | 1994-02-24 | ブリガム・アンド・ウイメンズ・ホスピタル | 主要血管事象を抑制するためのベータ−カロテン及びビタミンe療法 |
DE4031094A1 (de) * | 1990-10-02 | 1992-04-09 | Basf Ag | Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten |
PH31204A (en) * | 1990-11-02 | 1998-05-05 | Fujisawa Pharmaceutical Co | Pharmaceutical composition. |
US5298246A (en) * | 1991-01-09 | 1994-03-29 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Stable pharmaceutical composition and method for its production |
CH681152A5 (de) * | 1991-06-04 | 1993-01-29 | Marigen S.A. | Neue biotenside und antitumorale ester und phosphatide mit vitamin-d- und vitamin-e-verbindungen, ihre herstellung und aufarbeitung zu spontan dispergierbaren konzentraten. |
EP0602137B1 (en) * | 1991-09-06 | 2002-01-23 | Cognis Australia Pty Ltd | Carotenoid composition |
EP0621773B1 (en) * | 1992-01-16 | 1998-11-25 | The Board Of Regents, The University Of Texas System | Formulation and use of carotenoids in treatment of cancer |
EP0643692B1 (en) * | 1992-06-04 | 1999-11-24 | Betatene Pty. Ltd. | High cis beta-carotene composition |
-
1994
- 1994-03-22 ES ES94911015T patent/ES2178651T3/es not_active Expired - Lifetime
- 1994-03-22 AT AT94911015T patent/ATE218855T1/de not_active IP Right Cessation
- 1994-03-22 AU AU63705/94A patent/AU696956B2/en not_active Ceased
- 1994-03-22 DE DE69430799T patent/DE69430799T2/de not_active Expired - Fee Related
- 1994-03-22 JP JP6520430A patent/JPH08510995A/ja not_active Withdrawn
- 1994-03-22 EP EP94911015A patent/EP0689427B1/en not_active Expired - Lifetime
- 1994-03-22 WO PCT/AU1994/000143 patent/WO1994021232A1/en active IP Right Grant
- 1994-03-22 US US08/525,623 patent/US5773026A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5773026A (en) | 1998-06-30 |
JPH08510995A (ja) | 1996-11-19 |
EP0689427A1 (en) | 1996-01-03 |
DE69430799D1 (de) | 2002-07-18 |
DE69430799T2 (de) | 2003-02-13 |
ATE218855T1 (de) | 2002-06-15 |
AU696956B2 (en) | 1998-09-24 |
EP0689427B1 (en) | 2002-06-12 |
EP0689427A4 (en) | 1998-04-15 |
AU6370594A (en) | 1994-10-11 |
WO1994021232A1 (en) | 1994-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2178651T3 (es) | Compuestos carotenoides terapeuticos deispersables en agua. | |
FI971412A0 (fi) | Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä | |
HK1001973A1 (en) | Sulfonamides | |
SG55184A1 (en) | New imidazopyridines | |
GB9514473D0 (en) | Chemical compounds | |
GR3033828T3 (en) | Substituted biphenyl compounds for the treatment of inflammation | |
DE69811111D1 (de) | Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung | |
HUT76553A (en) | Use of gel formulations as dressing agents | |
ZA913627B (en) | New sulphonyl compounds | |
FR2690162B1 (fr) | Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation. | |
GB9206768D0 (en) | New compounds for use in the treatment of cancer | |
ES2145772T3 (es) | Uso de un complejo de ibuprofeno-beta-ciclodextrina para administracion oral. | |
TR200001909T2 (tr) | Matris metaloprotez inhibitörleri. | |
DE69510545D1 (de) | Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine | |
GB2324091A (en) | Metalloproteinase inhibitors | |
IL108288A0 (en) | Pyrrolidine derivatives, their preparation and medicaments containing them | |
DE59308187D1 (en) | Substituierte ortho-ethenylphenylessigsäurederivate | |
AUPM493194A0 (en) | Therapeutic agent for inhibiting the conversion of epithelial cells to tumours | |
NO983217D0 (no) | Terapeutiske anti-astmamidler som inneholder selenforbindeler | |
AP9901637A0 (en) | Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid. | |
DK0713485T3 (da) | Thiocarbamoylforbindelser som mikrobicider | |
IL107917A0 (en) | Triazoloquinazolines, their preparation and their use as medicaments | |
HK1039451A1 (en) | Use of catechol derivatives as proteinase inhibitors | |
IL117734A0 (en) | Beta-carbolines and pharmaceutical compositions containing them |